肿瘤坏死因子中和策略在黎巴嫩类风湿关节炎以外的风湿性疾病中的应用。 - Suppr

The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.

作者信息

Uthman Imad, Mroueh Kamel, Arayssi Thuraya, Nasr Fuad, Masri Abdul-Fattah

出版信息

Semin Arthritis Rheum. 2004 Jun;33(6):422-3. doi: 10.1016/j.semarthrit.2003.12.005.

DOI:10.1016/j.semarthrit.2003.12.005

PMID:15260002

Abstract

摘要

相似文献

The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.

Semin Arthritis Rheum. 2004 Jun;33(6):422-3. doi: 10.1016/j.semarthrit.2003.12.005.

Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis.

Semin Arthritis Rheum. 2003 Aug;33(1):1-18. doi: 10.1053/sarh.2003.50022.

The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseases.

Isr Med Assoc J. 2000 Dec;2 Suppl:11-2.

Infliximab treatment for rheumatic disease: clinical and radiological efficacy.

Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii67-9. doi: 10.1136/ard.61.suppl_2.ii67.

Rheumatoid vasculitis treated with infliximab.

J Rheumatol. 2005 Aug;32(8):1607-9.

Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors.

Clin Infect Dis. 2009 Sep 15;49(6):924-7. doi: 10.1086/605498.

[Autoimmune aspects of treatment with TNF-alpha inhibitors].

Postepy Hig Med Dosw (Online). 2007 Aug 28;61:478-84.

The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Rheumatol Int. 2009 Aug;29(10):1255-7. doi: 10.1007/s00296-008-0816-0. Epub 2008 Dec 4.

The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.

Int J Rheum Dis. 2009 Jul;12(2):118-24. doi: 10.1111/j.1756-185X.2009.01393.x.

[Swiss registry for TNF-alpha blockers in children and adolescents with rheumatological diseases].

Praxis (Bern 1994). 2010 May 26;99(11):649-54. doi: 10.1024/1661-8157/a000144.

引用本文的文献

Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data.

BioDrugs. 2023 Nov;37(6):813-828. doi: 10.1007/s40259-023-00613-6. Epub 2023 Jun 29.

The Use of Infliximab (Remicade®) for the Treatment of Rheumatic Diseases at a Tertiary Center in Lebanon: A 17-Year Retrospective Chart Review.

Mediterr J Rheumatol. 2020 Dec 22;31(4):400-405. doi: 10.31138/mjr.31.4.400. eCollection 2020 Dec.

The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Rheumatol Int. 2009 Aug;29(10):1255-7. doi: 10.1007/s00296-008-0816-0. Epub 2008 Dec 4.

Infliximab as monotherapy in giant cell arteritis.

Clin Rheumatol. 2006 Feb;25(1):109-10. doi: 10.1007/s10067-005-1115-8. Epub 2005 May 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.

作者信息

出版信息